Tübingen, Germany

Sascha Dammeier

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet, Erbe Elektromedizin Gmbh. Active years: 2019-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sascha Dammeier: Innovator in Disease Diagnosis

Introduction

Sascha Dammeier is a notable inventor based in Tuebingen, Germany. He has made significant contributions to the field of medical diagnostics, particularly in understanding diseases mediated via the alternative pathway of the complement system. His innovative approach has the potential to enhance disease diagnosis and risk assessment.

Latest Patents

Sascha Dammeier holds a patent titled "Method for the diagnosis of or risk for a disease mediated via the alternative pathway of the complement system." This invention relates to a method for diagnosing a disease or assessing the risk of developing a disease, specifically those mediated by the alternative pathway of the complement system. It also introduces a novel diagnostic marker and methods for identifying active agents. He has 1 patent to his name.

Career Highlights

Throughout his career, Sascha has been associated with prestigious institutions such as Eberhard Karls Universität Tübingen and its Medical Faculty. His work in these institutions has allowed him to contribute to significant advancements in medical research and diagnostics.

Collaborations

Sascha has collaborated with notable colleagues, including Eloed Koertvély and Marius Ueffing. These collaborations have further enriched his research and innovation efforts.

Conclusion

Sascha Dammeier's contributions to medical diagnostics exemplify the impact of innovative thinking in healthcare. His work continues to pave the way for advancements in disease diagnosis and risk assessment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…